WELLINGTON MANAGEMENT GROUP LLP
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 902219
Boston, MA
Position in VRDN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$60,216,512
-$1,133,795 QoQ
Shares Held
3,078,554
+56.2% QoQ
Ownership
2.99%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
16 quarters on record
Voting authority
Sole 0%
Shared 86%
None 14%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,418,547,095 across 180 Biotechnology names. VRDN ranks #43 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,212,589 | $1,434,549,489 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,837,459 | $1,419,694,318 | |
| 3 | ARGX |
Argenx SE
|
1,021,457 | $745,918,971 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,935,925 | $640,539,501 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
6,027,819 | $586,205,394 | |
| 6 | CYTK |
Cytokinetics Inc
|
8,009,489 | $527,905,416 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
6,391,816 | $479,961,458 | |
| 8 | ASND |
Ascendis Pharma A/S
|
1,757,633 | $402,023,391 |
All Filings in VRDN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $60,216,512 | 3,078,554 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $61,350,307 | 1,971,411 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $24,224,237 | 1,122,532 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,782,189 | 270,543 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,358,810 | 249,170 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,303,355 | 224,484 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $5,368,703 | 235,987 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,695,410 | 284,044 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,216,913 | 240,829 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,183,871 | 192,097 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $3,308,040 | 215,648 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,098,992 | 172,299 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,164,633 | 124,396 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,519,892 | 120,503 | Shares | Defined | 2023-02-13 | |
| 2021-06-30 | $10,581,862 | 578,560 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $9,667,737 | 578,560 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||